person · Reporting owner

Seim Robin Gene

Disclosed activity across 1 company

Tapewire entity: 41982
SEC CIK: 0001351911

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
OMNICELL, INC.OMCL · Entity 4666	Director	June 01, 2026	June 03, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

OMNICELL, INC.

Report date June 01, 2026 · Filed June 03, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	52,198	Reported balance After 2026-06-01 transaction · row 1 1 source row Row 1 · 2026-06-01 · Grant · Acquired 4,845 · Balance 52,198 F1: Grant of restricted shares, under the Issuer's equity incentive plan, in consideration of services as a Board Member pursuant to the Issuer's Board of Directors Compensation Plan. Shares shall vest in full on the one-year anniversary of the grant date.

Filing footnotes · ownership attribution and instrument terms

F1: Grant of restricted shares, under the Issuer's equity incentive plan, in consideration of services as a Board Member pursuant to the Issuer's Board of Directors Compensation Plan. Shares shall vest in full on the one-year anniversary of the grant date.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
June 15, 2017 Filed Jun 16, 2017 21:38 UTC	OMNICELL, INC. OMCL · Entity 4666	Tax withholdingCommon Stock	1,597	$42.95	$68,591.15	Disclosure SEC source: 0001179110-17-009218 · edgar.xml · nonDerivative · entry 3 Seim Robin Gene · CIK 0001351911 · EVP, Global A & M Adherence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,144 F1 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document
June 15, 2017 Filed Jun 16, 2017 21:38 UTC	OMNICELL, INC. OMCL · Entity 4666	Tax withholdingCommon Stock	2,073	$42.95	$89,035.35	Disclosure SEC source: 0001179110-17-009218 · edgar.xml · nonDerivative · entry 2 Seim Robin Gene · CIK 0001351911 · EVP, Global A & M Adherence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,741 F1 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document
March 07, 2017 Filed Mar 9, 2017 22:13 UTC	OMNICELL, INC. OMCL · Entity 4666	Tax withholdingCommon Stock	1,077	$0.00	$0.00	Disclosure SEC source: 0001179110-17-004337 · edgar.xml · nonDerivative · entry 2 Seim Robin Gene · CIK 0001351911 · EVP, Global A & M Adherence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,814 F1 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document
February 08, 2017 Filed Feb 11, 2017 00:25 UTC	OMNICELL, INC. OMCL · Entity 4666	GrantStock Option (Right to Buy) · Derivative	34,390	$0.00 Strike: $36.70	$0.00	Disclosure SEC source: 0001179110-17-002190 · edgar.xml · derivative · entry 4 Seim Robin Gene · CIK 0001351911 · EVP, Global A & M Adherence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,390 Underlying: Common Stock · 34,390 shares Expires 2027-02-08 F2 · shares: Shares shall vest ratably over 48 month period, with a year cliff. Read SEC document
February 08, 2017 Filed Feb 11, 2017 00:25 UTC	OMNICELL, INC. OMCL · Entity 4666	GrantCommon Stock	13,960	$0.00	$0.00	Disclosure SEC source: 0001179110-17-002190 · edgar.xml · nonDerivative · entry 3 Seim Robin Gene · CIK 0001351911 · EVP, Global A & M Adherence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,891 F3 · shares: The Performance-based restricted stock unit awards vest as to 25% of the shares on the date of the Compensation Committee meeting in 2018 when the Committee reviews the performance-based metrics and determines if they were met or not with the remaining shares vesting on a semi-annual basis over a period of thirty-six months commencing on June 15, 2018 if the Company meets certain stock performance objectives compared to the NASDAQ Healthcare Index. The actual number of performance based stock awards that vest may be 0%, 50% or 100% of the numbers reflected above, depending upon the Company's performance. Read SEC document
February 08, 2017 Filed Feb 11, 2017 00:25 UTC	OMNICELL, INC. OMCL · Entity 4666	GrantCommon Stock	4,190	$0.00	$0.00	Disclosure SEC source: 0001179110-17-002190 · edgar.xml · nonDerivative · entry 2 Seim Robin Gene · CIK 0001351911 · EVP, Global A & M Adherence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,931 F1 · shares: Restricted Stock Units shall vest semiannually on 6/15 and 12/15 for a period of 4 years. Read SEC document
December 15, 2016 Filed Dec 16, 2016 22:42 UTC	OMNICELL, INC. OMCL · Entity 4666	Tax withholdingCommon Stock	5,377	$33.90	$182,280.30	Disclosure SEC source: 0001179110-16-033148 · edgar.xml · nonDerivative · entry 2 Seim Robin Gene · CIK 0001351911 · EVP, Global A & M Adherence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,741 F1 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.